Analysts await HCP, Inc. (NASDAQ:HCP) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $0.69 EPS, down 14.49% or $0.1 from last year’s $0.79 per share.

At the moment 17 analysts are watching HCP, Inc. (NASDAQ:HCP), 0 rate it “Buy”, 1 “Outperform”, 9 “Underperform”, 5 “Sell”, while 2 “Hold”.

Looking forward, for the quarter ending Jun-16, 2 analysts have a mean sales target of 637.49 million. For the quarter ending Sep-16, 2 analysts have a mean sales target of 647.30 million whilst for the year ending Dec-16, 6 analysts have a mean target of 2,566.65 million.

In terms of earnings per share, 16 analysts have a 0.68 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 16 analysts have a 0.69 EPS mean target and for the quarter ending Sep-16 there are 18 estimates of 2.76 EPS.

The biggest institutional shareholders in HCP, Inc. include Vanguard Group Inc which owns 61 million shares in the company valued at $2.34 B million. State Street Corp is the second biggest holder with 37 million shares currently valued at 1.40 B million whilst Invesco Advisers, Inc has 23 million shares valued at 897.12 million.

Total shares held by institutions as of the most recent company filings are 406,960,070 with a reported 46,650,026 bought and 31,845,890 sold. These holdings make up 87.76% of the company’s outstanding shares.

Currently insiders hold 3,994,495 shares in the business which makes up 0.86% of shares. The biggest holder currently is James F. Flaherty,III who owns 861,753 shares (0.19% of those outstanding), whilst James G. Reynolds holds 465,188 (0.10% of shares outstanding) and Stephen R. Maulbetsch holds 313,680 (0.07% of shares outstanding).

The stock increased 0.96% or $0.33 during the last trading session, hitting $36.22. HCP, Inc. (NASDAQ:HCP) has risen 11.62% over the past 6 months and is uptrending.